I don't understand why this article continually mixes one thing tests do(measuring physical quantities) with another(predicting disease) ? The way to evaluate theranos is whether they measure the physical quantities correctly(and it appears they are not), not with the complexity of predicting disease from those numbers. That's a job for other parts of the medical establishment.